274 results on '"Geissler, Jan"'
Search Results
2. Vom Patienten zum Akteur in der Nationalen Dekade gegen Krebs
3. A New Framework for Co-Creating Telehealth for Cancer Care with the Patient Community
4. Adopting recommendations for implementing patient involvement in cancer research: a funder’s approach
5. Veränderungen durch die neue EU-Verordnung 536/2014 zu klinischen Prüfungen aus Patientensicht
6. Precision oncology medicines and the need for real world evidence acceptance in health technology assessment: Importance of patient involvement in sustainable healthcare
7. An inter-specialty cancer training programme curriculum for Europe
8. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
9. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
10. Evolving assessment pathways for precision oncology medicines to improve patient access: a tumor-agnostic lens
11. Delivering precision oncology to patients with cancer
12. Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools
13. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
14. Patient involvement in clinical trials
15. Patient authorship of medical research publications: An evolution, revolution, and solution?
16. Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)
17. Patients’ knowledge, preferences, and perspectives about data protection and data control: an exploratory survey
18. The European Code of Cancer Practice
19. An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry
20. Delivering Digital Health Solutions that Patients Need: A Call to Action
21. Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs
22. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
23. P1688: LIVING WITH ACUTE LEUKEMIA: A GLOBAL SURVEY OF PATIENTS AND CARERS EXPERIENCE
24. Role of Patient Organisations
25. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
26. Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting
27. Understanding Quality of Life in Patients With Acute Leukemia, a Global Survey
28. Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)
29. The European Cancer Patient’s Bill of Rights, update and implementation 2016
30. Efficacy and Safety Results from ASC4MORE, a Randomized Study of Asciminib (ASC) Add-on to Imatinib (IMA), Continued IMA, or Switch to Nilotinib (NIL) in Patients (Pts) with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Not Achieving Deep Molecular Responses (DMRs) with ≥1 Year of IMA
31. Differences in Experiences Reported By Patients with Acute and Chronic Leukemia: A Global Survey
32. Pan-Stakeholder Core Outcome Set (COS) Definition for Hematological Malignancies within the Framework of Harmony and Harmony PLUS Projects
33. Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries
34. Culture and Process Change as a Priority for Patient Engagement in Medicines Development
35. Mobile Music
36. Repertorium der krankheitsunabhängigen, charakteristischen sichtbaren und direkt erfassbaren Symptome
37. Homöopathische Behandlung
38. Verlaufsbeurteilung
39. Homöopathische Potenzen und ihre Dosierung
40. Lunge
41. Stoffwechsel und Hormonsystem
42. Materia medica (Arzneimittelbilder)
43. Vorwort zur 3. Auflage
44. Das Repertorium
45. Vorwort zur 1. Auflage
46. Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action
47. Abstract 4094: WAYFIND-R: Delivering a high-quality real-world data (RWD) global registry of patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS)
48. Abstract 5246: Conceptualization of core clinico-molecular variables for registries enrolling patients diagnosed with a solid tumor and profiled with next-generation sequencing (NGS)
49. Improving outcomes through patient-generated evidence—the next step in patient advocacy
50. Delivering affordable cancer care in high-income countries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.